Đang chuẩn bị liên kết để tải về tài liệu:
Drug repositioning for non-small cell lung cancer by using machine learning algorithms and topological graph theory

Trung Nghĩa 78 14 pdf

Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ Tải xuống

Non-small cell lung cancer (NSCLC) is one of the leading causes of death globally, and research into NSCLC has been accumulating steadily over several years. Drug repositioning is the current trend in the pharmaceutical industry for identifying potential new uses for existing drugs and accelerating the development process of drugs, as well as reducing side effects. |

TÀI LIỆU LIÊN QUAN

Drug repositioning using drug-disease vectors based on an integrated network

Additional neural matrix factorization model for computational drug repositioning

Realizing drug repositioning by adapting a recommendation system to handle the process

A phenome-guided drug repositioning through a latent variable model

Hybrid attentional memory network for computational drug repositioning

Drug voyager: A computational platform for exploring unintended drug action

Drug repositioning for enzyme modulator based on human metabolite-likeness

Drug repositioning for non-small cell lung cancer by using machine learning algorithms and topological graph theory

Drug repositioning for orphan genetic diseases through Conserved Anticoexpressed Gene Clusters (CAGCs)

The assessment of efficient representation of drug features using deep learning for drug repositioning

Đã phát hiện trình chặn quảng cáo AdBlock

Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.